Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-009586
Filing Date
2014-05-20
Accepted
2014-05-20 16:37:41
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q epct20140331_10q.htm 10-Q 1121608
2 EXHIBIT 31.1 ex31-1.htm EX-31 11102
3 EXHIBIT 31.2 ex31-2.htm EX-31 10858
4 EXHIBIT 32.1 ex32-1.htm EX-32 6535
5 EXHIBIT 32.2 ex32-2.htm EX-32 6491
  Complete submission text file 0001437749-14-009586.txt   10069958

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS imnp-20140331.xml EX-101.INS 1545928
7 EXHIBIT 101.SCH imnp-20140331.xsd EX-101.SCH 93515
8 EXHIBIT 101.CAL imnp-20140331_cal.xml EX-101.CAL 39569
9 EXHIBIT 101.DEF imnp-20140331_def.xml EX-101.DEF 442769
10 EXHIBIT 101.LAB imnp-20140331_lab.xml EX-101.LAB 721819
11 EXHIBIT 101.PRE imnp-20140331_pre.xml EX-101.PRE 437135
Mailing Address 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591 914-606-3500
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51290 | Film No.: 14858370
SIC: 2834 Pharmaceutical Preparations